PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27579889-4	2016	Our results revealed that beta2-GPI dose-dependently decreased the VEGF-induced increase in endothelial cell proliferation, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the bromodeoxyuridine (BrdU) incorporation assays.	thiazolyl blue	134-194	vascular endothelial growth factor A	Homo sapiens	67-71	
27123081-4	2016	The selective killing effect of Ad-VEGFp-CDglyTK was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and flow cytometry (FCM) in vitro and by xenograft studies in vivo.	thiazolyl blue	65-125	vascular endothelial growth factor A	Homo sapiens	35-40	
23765166-6	2013	3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide results also showed that VEGF significantly enhanced the IC50 of the cells treated with adriamycin.	thiazolyl blue	0-61	vascular endothelial growth factor A	Homo sapiens	87-91	
14966912-9	2004	The transfection of antisense VEGF(165) gene resulted in the inhibitory effect on the proliferation of hepatocarcinoma cells by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and the death of all hepatocarcinoma cells on day 6 after transfection.	thiazolyl blue	128-190	vascular endothelial growth factor A	Homo sapiens	30-34